New 3D printer aims to make bioprinting more accessible with uses that range from personalised drugs to human spare parts.
A new adhesive that mimics the sticky substance barnacles use to cling to rocks may offer a better way to treat traumatic injuries.
Rare diseases aren’t so rare. Collectively, up to 30 million Americans, many of them children, are born with one of the approximately 7,000 known rare diseases. Most of these millions of people also share a common genetic feature: their diseases are caused by an alteration in a single gene.
Many of these alterations could theoretically be targeted with therapies designed to correct or replace the faulty gene. But there have been significant obstacles in realizing this dream. The science of gene therapy has been making real progress, but pursuing promising approaches all the way to clinical trials and gaining approval from the U.S. Food and Drug Administration (FDA) is still very difficult. Another challenge is economic: for the rarest of these conditions (which is most of them), the market is so small that most companies have no financial incentive to pursue them.
To overcome these obstacles and provide hope for those with rare diseases, we need a new way of doing things. One way to do things differently—and more efficiently—is the recently launched Bespoke Gene Therapy Consortium (BGTC). It is a bold partnership of NIH, the FDA, 10 pharmaceutical companies, and several non-profit organizations [1]. Its aim: optimize the gene therapy development process and help fill the significant unmet medical needs of people with rare diseases.
LISBON, Nov 2 (Reuters) — Chip designer Advanced Micro Devices (AMD.O) has been able to skirt most of the problems linked with the global chip supply shortage by forecasting demand years in advance, a top executive said on Tuesday.
Demand for electronics gadgets from people stuck in homes due to the pandemic has led to a shortage of semiconductors that are used from anything from mobile phones and cars.
But despite a squeeze in supply, AMD has been able to take market share away from rival Intel (INTC.O) in both PCs and servers with its latest line of processors.
Fighting The Battle Against Biological Aging — Dr. Eric Verdin MD, President & CEO, Buck Institute for Research on Aging.
Dr. Eric Verdin, MD (https://www.buckinstitute.org/lab/verdin-lab/) is President and Chief Executive Officer of the Buck Institute for Research on Aging, as well as Professor of Medicine at University of California, San Francisco (https://bms.ucsf.edu/people/eric-verdin-md).
Ebola Vaccine: Information about Ervebo® | Clinicians | Ebola (Ebola Virus Disease) | CDC.
A safe and effective vaccine is an important tool to protect frontline workers and prevent the introduction and spread of Ebola in the United States.
Ebola virus is a zoonotic pathogen that causes severe hemorrhagic fever in humans, known as Ebola virus disease (EVD). There are four species of Ebola virus that have been known to cause disease in humans. Of these, species Zaire ebolavirus (EBOV) is the most lethal, with case fatality rates of 70–90% if left untreated. EBOV is responsible for the majority of recorded EVD outbreaks. This includes the two largest EVD outbreaks in history, the 2014–2016 West Africa outbreak and the 2018 outbreak in eastern Democratic Republic of the Congo, where over 32,000 people were infected, and more than 13,600 deaths were reported.
Continue reading “Ebola Vaccine: Information about Ervebo®” »
Displacing Delta. Expect this to dominate globally in the coming year, if truly 10% more transmissible.
An offshoot of the Delta coronavirus variant which is slowly spreading throughout the UK is expected to be dominant within a matter of months, experts believe.
Known as AY.4.2, the sub-variant is thought to be at least 10 cent more transmissible than its predecessor, with analysis underway to determine what accounts for its increased infectiousness.
Continue reading “Delta sub-variant expected to be dominant in UK” »
For the first time ever, Scientists working for the United States Government and Google have managed to read and understand a portion of a brain in real time. This is going to enable abilities such as reading minds and memories from humans in the future. The question is how long it will take until the government starts secret projects in that area for bad purposes.
The Human Brain Project is the biggest secret scientific research project, based on exascale supercomputers, that aims to build a collaborative ICT-based scientific research infrastructure to allow researchers across Europe and the United States Government to advance knowledge in the fields of neuroscience, computing, and brain-related medicine and in the end to create a device in the form of a brain computer interface that can record and read memories from a human brain.
–
Every day is a day closer to the Technological Singularity. Experience Robots learning to walk & think, humans flying to Mars and us finally merging with technology itself. And as all of that happens, we at AI News cover the absolute cutting edge best technology inventions of Humanity.
Continue reading “Reading Memories from the Human Brain — SECRET Brain Project” »
A new algorithm created by researchers at Mount Sinai Hospital, New York, has learned to identify subtle changes in electrocardiograms (ECGs) to predict whether a patient is developing heart failure.
